The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of shares

9 Apr 2020 07:04

RNS Number : 3385J
Danakali Limited
09 April 2020
 

Announcement

Thursday, 9 April 2020

 

Issue of shares

 

Danakali Limited (ASX: DNK / LSE: DNK) (Danakali, or the Company) confirms that it has issued 20,000 new fully paid shares to an employee, constituting a PDMR, as detailed below, on the vesting of performance rights.

 

A completed Appendix 2A has been lodged together with this announcement and is available for download at: https://www.asx.com.au/asxpdf/20200409/pdf/44gvfc1042mtgt.pdf.

 

Secondary Trading Exemption - s708A Notice

 

Danakali gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Act) of the following:

· The shares were issued without disclosure under Part 6D 2 of the Act;

· This notice is being given under section 708A(5)(e) of the Act;

· As at the date of this notice, the Company has complied with:

The provisions of Chapter 2M of the Act as they apply to the Company; and

Section 674 of the Act; and

· As at the date of this notice, there is no information:

That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

o The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

o The rights and liabilities attaching to the shares.

 

Total voting rights

 

The Company advises that it has, conditional on admission, allotted and issued 20,000 new fully paid ordinary shares of no par value in the Company (Ordinary Shares).

 

Application has been made to the UK Listing Authority for the admission of those 20,000 new Ordinary Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's Main Market for listed securities and it is expected that dealings will commence on 16 April 2020. The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue.

 

Following admission, the Company will have in issue a total of 318,741,306 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury.

 

Therefore, the total number of voting rights in the Company is 318,741,306 which may be used by shareholders or other persons as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

 

Notification of PDMR transaction

 

The Company has received notification from a person discharging managerial responsibilities (PDMR) with respect to 20,000 fully paid ordinary shares issued by the Company on the vesting of performance rights.

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Tony Harrington

2

 

Reason for the notification

a)

 

Position/status

 

PDMR (Project Director)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

Danakali Limited

b)

 

LEI

5493004SQ5E5Q6VRT472

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Fully paid ordinary shares

 

Identification code

AU000000DNK9

b)

 

Nature of the transaction

 

Award of shares on the vesting of performance rights

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

20,000

 

d)

Aggregated information

- Aggregated volume

- Price

- Total

 

N/A

e)

 

Date of the transaction

 

8 April 2020

f)

Place of the transaction

 

Outside a trading venue

 

For more information, please contact:

 

Danakali

 

Niels Wage

Chief Executive Officer

+61 8 6189 8635

Todd Romaine

Chief Sustainability Officer

+1 (604) 365 5999

 

Corporate Broker - Numis Securities

 

UK IR/PR - Instinctif Partners

John Prior / James Black / Paul Gillam

+44 (0)20 7260 1000

Mark Garraway / Sarah Hourahane / Dinara Shikhametova

danakali@instinctif.com

+44 (0)207 457 2020

 

Announcement authorised for release by the Company Secretary of Danakali.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKKCBKABKKKQK
Date   Source Headline
12th Oct 20067:15 amRNSDisposal of Danka Europe
28th Sep 20067:45 amRNSAsset Disposal Strategy
27th Sep 20064:41 pmRNSSecond Price Monitoring Extn
27th Sep 20064:36 pmRNSPrice Monitoring Extension
13th Sep 20068:39 amRNSAdditional Listing
5th Sep 20069:57 amRNSBlocklisting Interim Review
31st Aug 20061:30 pmRNSCompletion of Disposal
17th Aug 20062:27 pmRNSIssue of Participating Shares
8th Aug 20061:30 pmRNS1st Quarter Results
17th Jul 20063:00 pmRNSDirectorate Change
3rd Jul 20064:37 pmRNSPrice Monitoring Extension
7th Jun 20061:30 pmRNSFinal Results
31st May 20064:00 pmRNSNotice of Results
25th May 20061:24 pmRNSDirector Declaration
19th May 20061:30 pmRNSDirectorate Change
16th May 200611:54 amRNSIssue of Participating Shares
21st Mar 20065:01 pmRNSDirector Declaration
14th Mar 20066:20 pmRNSDirectorate Change
7th Feb 20061:30 pmRNS3rd Quarter Results
26th Jan 20064:00 pmRNSNotice of Results
17th Jan 20063:00 pmRNSRe Contract
21st Dec 20055:50 pmRNSHolding(s) in Company
21st Dec 20053:42 pmRNSRe Agreement with Kodak
24th Nov 20055:26 pmRNSHolding(s) in Company
16th Nov 20054:19 pmRNSIssue of Participating Shares
10th Nov 20055:30 pmRNSHolding(s) in Company
9th Nov 20055:44 pmRNSResult of AGM
3rd Nov 20051:30 pmRNSInterim Results
28th Oct 20053:04 pmRNSNotice of Results
19th Oct 20053:33 pmRNSBlocklisting Interim Review
17th Oct 20056:07 pmRNSHolding(s) in Company
7th Oct 20053:00 pmRNSDirectorate Change
3rd Oct 20051:30 pmRNSRe MCI Outsourcing Agreement
28th Sep 20053:32 pmRNSHolding(s) in Company
27th Sep 200510:00 amRNSHolding(s) in Company
26th Sep 20057:13 amRNSLatin American Disposals
20th Sep 20055:00 pmRNSAnnual Report and Accounts
8th Sep 20055:21 pmRNSDirectors' Shareholdings
17th Aug 200510:15 amRNSIssue of Participating Shares
16th Aug 20055:51 pmRNSGrant Of Options
16th Aug 20052:01 pmRNSGrant Of Options
3rd Aug 20051:45 pmRNS1st Quarter Results
1st Aug 20053:30 pmRNSGevity Outsourcing Agreement
28th Jul 20053:00 pmRNSNotice of Results
19th Jul 200512:00 pmRNSMCI Outsourcing Agreement
5th Jul 20056:24 pmRNSAppointment of CFO - Amend
5th Jul 20053:30 pmRNSAppointment of CFO
1st Jul 20057:01 amRNSSale of Danka Canada Inc.
10th Jun 20052:41 pmRNSFinal Results - Amendment
10th Jun 20051:34 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.